Gene Editing for Treatment and Prevention of Human Diseases: A Global Survey of Gene Editing-Related Researchers.

Abstract:

:In the next decades, gene editing technologies are expected to be used in the treatment and prevention of human diseases. Yet, the future uses of gene editing in medicine are still unknown, including its applicability and effectiveness to the treatment and prevention of infectious diseases, cancer, and monogenic and polygenic hereditary diseases. This study aims to address this gap by analyzing the views of over 1,000 gene editing-related researchers from all over the world. Some of our survey results show that, in the next 10 years, DNA double-strand breaks are expected to be the main method for gene editing, and CRISPR-Cas systems to be the mainstream programmable nuclease. In the same period, gene editing is expected to have more applicability and effectiveness to treat and prevent infectious diseases and cancer. Off-targeting mutations, reaching therapeutic levels of editing efficiency, difficulties in targeting specific tissues in vivo, and regulatory and ethical challenges are among the most relevant factors that might hamper the use of gene editing in humans. In conclusion, our results suggest that gene editing might become a reality to the treatment and prevention of a variety of human diseases in the coming 10 years. If the future confirms these researchers' expectations, gene editing could change the way medicine, health systems, and public health deal with the treatment and prevention of human diseases.

journal_name

Hum Gene Ther

journal_title

Human gene therapy

authors

Rocha LFM,Braga LAM,Mota FB

doi

10.1089/hum.2020.136

subject

Has Abstract

pub_date

2020-08-01 00:00:00

pages

852-862

issue

15-16

eissn

1043-0342

issn

1557-7422

journal_volume

31

pub_type

杂志文章
  • Cancer gene therapy by direct tumor injections of a nonviral T7 vector encoding a thymidine kinase gene.

    abstract::Previously, we described a nonviral cytoplasmic gene therapy vector system based on the T7 autogene concept. This system has been shown to achieve rapid and high levels of gene expression in a variety of animal cells and tissues. To test the utility of the system in vivo tumor ablation, a T7 cancer gene therapy plasmi...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.5-729

    authors: Chen X,Li Y,Xiong K,Aizicovici S,Xie Y,Zhu Q,Sturtz F,Shulok J,Snodgrass R,Wagner TE,Platika D

    更新日期:1998-03-20 00:00:00

  • Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain.

    abstract::RNA interference (RNAi) is an evolutionarily conserved mechanism of posttranscriptional gene-specific silencing. For in vivo applications, RNAi has been hampered until recently by inefficient delivery methods and by the transient nature of the gene suppression. Lentiviral vectors (LVs) hold great promise for gene ther...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303403322611809

    authors: Van den Haute C,Eggermont K,Nuttin B,Debyser Z,Baekelandt V

    更新日期:2003-12-10 00:00:00

  • Retrovirus-mediated transfer and expression of beta-hexosaminidase alpha-chain cDNA in human fibroblasts from G(M2)-gangliosidosis B1 variant.

    abstract::Mutations in the alpha-chain of lysosomal hexosaminidase (EC 3.2.1.52) underlie two distinct biochemical phenotypes known as variant B and variant B1 of G(M2) gangliosidosis. This paper shows that the transduction of human B1-type fibroblasts (producing catalytically inactive alpha-chains) with a retroviral vector enc...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303401750476267

    authors: Teixeira CA,Sena-Esteves M,Lopes L,Sá Miranda MC,Ribeiro MG

    更新日期:2001-09-20 00:00:00

  • Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice.

    abstract::We previously demonstrated that intramuscular plasmid injection serves as a useful method of long-term systemic delivery of cytokines. In the present study, we assess intramuscular DNA injection as a means of systemically delivering interleukin 10 (IL-10), a cytokine with immunosuppressive properties, and preventing t...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.12-1701

    authors: Nitta Y,Tashiro F,Tokui M,Shimada A,Takei I,Tabayashi K,Miyazaki J

    更新日期:1998-08-10 00:00:00

  • Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transfer.

    abstract::Mucopolysaccharidosis type IIIA (MPSIIIA) is a rare lysosomal storage disorder caused by mutations in the sulfamidase gene. Accumulation of glycosaminoglycan (GAG) inside the lysosomes is associated with severe neurodegeneration as well as peripheral organ pathological changes leading to death of affected individuals ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2012.029

    authors: Ruzo A,Marcó S,García M,Villacampa P,Ribera A,Ayuso E,Maggioni L,Mingozzi F,Haurigot V,Bosch F

    更新日期:2012-12-01 00:00:00

  • Gene therapy in ophthalmology: validation on cultured retinal cells and explants from postmortem human eyes.

    abstract::Gene therapy studies in primates can provide important information regarding vector tropism, specific cellular expression, biodistribution, and safety prior to clinical trials. In this study, we report the assessment of transduction efficiency of recombinant adeno-associated virus (rAAV) vectors using human postmortem...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2010.157

    authors: Fradot M,Busskamp V,Forster V,Cronin T,Léveillard T,Bennett J,Sahel JA,Roska B,Picaud S

    更新日期:2011-05-01 00:00:00

  • Adenoviral gene transfer of sphingosine kinase 1 protects heart against ischemia/reperfusion-induced injury and attenuates its postischemic failure.

    abstract::Sphingosine kinase 1 (SPK1) has been identified as a central mediator of ischemia preconditioning and plays a protective role in ischemia/reperfusion (I/R)-induced cardiomyocyte death. In the present study, we investigated the protective effect of adenovirus-mediated SPK1 gene (Ad-SPK1) transfer on I/R-induced cardiac...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2007.036

    authors: Duan HF,Wang H,Yi J,Liu HJ,Zhang QW,Li LB,Zhang T,Lu Y,Wu CT,Wang LS

    更新日期:2007-11-01 00:00:00

  • Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.

    abstract::Transfer of a herpes simplex virus-derived thymidine kinase (HSV-tk) gene into brain tumor cells and subsequent ganciclovir (GCV) treatment has been shown by others to be an effective treatment in rats with intracerebrally inoculated 9L gliosarcomas. Mechanism of action and reproducibility are, however, still a matter...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1996.7.2-197

    authors: Vincent AJ,Vogels R,Someren GV,Esandi MC,Noteboom JL,Avezaat CJ,Vecht C,Bekkum DW,Valerio D,Bout A,Hoogerbrugge PM

    更新日期:1996-01-20 00:00:00

  • Poor expression of MDR1 transgene in HeLa cells by bicistronic Moloney murine leukemia virus-based vector.

    abstract::Cotransfer of a therapeutic gene together with the human MDR1 gene provides an opportunity to increase the number of transduced marrow cells, expressing the therapeutic gene, by in vivo selection for MDR1. We have used an Lg-MDR1-IRES-neo (LgMIN) retroviral vector, containing MDR1 and neo genes, separated by the EMCV ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.15-2263

    authors: Zaboikin MM,Schuening FG

    更新日期:1998-10-10 00:00:00

  • Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa.

    abstract::Laminin-5 is composed of three distinct polypeptides, alpha3, beta3, and gamma2, which are encoded by three different genes, LAMA3, LAMB3, and LAMC2, respectively. We have isolated epidermal keratinocytes from a patient presenting with a lethal form of junctional epidermolysis bullosa characterized by a homozygous mut...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.9-1359

    authors: Dellambra E,Vailly J,Pellegrini G,Bondanza S,Golisano O,Macchia C,Zambruno G,Meneguzzi G,De Luca M

    更新日期:1998-06-10 00:00:00

  • Efficient bone marrow transduction by gene transfer with allogeneic umbilical cord blood serum and plasma: an implication for clinical trials.

    abstract::Low in vivo transduction efficiency and safety concerns have been hurdles for effective hematopoietic stem cell (HSC) gene therapy. Here, we investigate whether the safety and efficiency of retroviral gene transfer into HSCs can be improved by using human allogeneic umbilical cord blood (UCB)-derived supplements inste...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2007.123

    authors: Moon N,Yang SJ,Park BB,Chung YS,Lee JW,Oh IH

    更新日期:2008-07-01 00:00:00

  • In vivo marking of spontaneous or vaccine-induced fibrosarcomas in the domestic house cat, using an adenoviral vector containing a bifunctional fusion protein, GAL-TEK.

    abstract::We evaluated the ability of a replication-deficient, recombinant adenoviral vector to transfer the bifunctional gene GAL-TEK, which expresses a marking/therapeutic gene product, to naturally occurring cat fibrosarcomas in situ. GAL-TEK contains an in-frame fusion of the bacterial LacZ gene for histochemical marking of...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1995.6.9-1215

    authors: Marini FC 3rd,Cannon JP,Belmont JW,Shillitoe EJ,Lapeyre JN

    更新日期:1995-09-01 00:00:00

  • EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo.

    abstract::Administration of recombinant adenoviral (AdV) vectors to animals can lead to inflammatory and immune responses. For therapeutic indications in which repeated treatment is necessary, such as cystic fibrosis (CF), these responses can limit the therapeutic usefulness of the vector. In principle, the utility of the vecto...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303401300042348

    authors: Chu Q,St George JA,Lukason M,Cheng SH,Scheule RK,Eastman SJ

    更新日期:2001-03-20 00:00:00

  • Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses.

    abstract::Umbilical cord blood (CB) from the early gestational human fetus is recognized as a rich source of hematopoietic stem cells. To examine the value of fetal CB for gene therapy of inborn immunohematopoietic disorders, we tested the feasibility of genetic modification of CD34(+) cells from CB at weeks 24 to 34 of pregnan...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340150504000

    authors: Luther-Wyrsch A,Costello E,Thali M,Buetti E,Nissen C,Surbek D,Holzgreve W,Gratwohl A,Tichelli A,Wodnar-Filipowicz A

    更新日期:2001-03-01 00:00:00

  • A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.

    abstract::Here we show potent inhibition of HIV-1 replication in a human T cell line and primary human CD4(+) cells by expressing a single antiviral protein. Nullbasic is a mutant form of the HIV-1 Tat protein that was previously shown to strongly inhibit HIV-1 replication in nonhematopoietic cell lines by targeting three steps...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2012.176

    authors: Apolloni A,Lin MH,Sivakumaran H,Li D,Kershaw MH,Harrich D

    更新日期:2013-03-01 00:00:00

  • Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors.

    abstract::The utility of first-generation adenovirus vectors for long-term gene transfer in humans is limited by preexisting antiadenoviral immunity. We demonstrate here that new-generation high-capacity adenovirus vectors (HC-Ads) can efficiently transduce the brain and mediate stable transgene expression for at least 2 months...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303401750148829

    authors: Thomas CE,Schiedner G,Kochanek S,Castro MG,Lowenstein PR

    更新日期:2001-05-01 00:00:00

  • Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery.

    abstract::The potential of short interfering RNA (siRNA) to be developed for therapeutic use against cancer depends on the availability of an efficient tumor-specific delivery vehicle. We have previously shown that a nanoscale nonviral liposome-based complex that includes an anti-transferrin receptor single-chain antibody fragm...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.17.117

    authors: Pirollo KF,Zon G,Rait A,Zhou Q,Yu W,Hogrefe R,Chang EH

    更新日期:2006-01-01 00:00:00

  • Heart-specific targeting of beta-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors.

    abstract::Adenoviruses are attractive vectors for gene transfer into cardiac muscle. However, their promiscuous tissue tropism, which leads to an ectopic expression of the transgene, is a considerable limitation. To restrict expression to cardiomyocytes, we have constructed two recombinant adenoviruses (Ad-MLC2-250betagal and A...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.13-1919

    authors: Griscelli F,Gilardi-Hebenstreit P,Hanania N,Franz WM,Opolon P,Perricaudet M,Ragot T

    更新日期:1998-09-01 00:00:00

  • Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway.

    abstract::Heme oxygenase 1 (HO-1) is an inducible enzyme that catalyzes heme to generate bilirubin, ferritin, and carbon monoxide. Because enhanced expression of HO-1 confers protection against many types of cell and tissue damage by modulating apoptotic cell death or cytokine expression profiles, we hypothesized that adenoviru...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340260355356

    authors: Tsuburai T,Suzuki M,Nagashima Y,Suzuki S,Inoue S,Hasiba T,Ueda A,Ikehara K,Matsuse T,Ishigatsubo Y

    更新日期:2002-11-01 00:00:00

  • Uptake, biodistribution, and time course of naked plasmid DNA trafficking after intratumoral in vivo jet injection.

    abstract::Nonviral jet injection is an applicable technology for in vivo gene transfer of naked DNA. However, little is known about the biodistribution and clearance of jet-injected DNA, or about its localization within tissue and cells. Therefore, in this study we analyzed the intratumoral and systemic biodistribution of jet-i...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.17.611

    authors: Walther W,Minow T,Martin R,Fichtner I,Schlag PM,Stein U

    更新日期:2006-06-01 00:00:00

  • Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.

    abstract::The immune response against human immunodeficiency virus type-1 (HIV-1) is believed to play a role in controlling the early stages of disease progression. The cellular immune response, in particular cytotoxic T lymphocyte (CTL) activity, may be important for eliminating virally infected cells in HIV-1-infected individ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1994.5.7-853

    authors: Laube LS,Burrascano M,Dejesus CE,Howard BD,Johnson MA,Lee WT,Lynn AE,Peters G,Ronlov GS,Townsend KS

    更新日期:1994-07-01 00:00:00

  • Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.

    abstract::Neurodegeneration in Parkinson's disease (PD) affects mainly dopaminergic neurons in the substantia nigra, where age-related, increasing percentages of cells lose detectable respiratory activity associated with depletion of intact mitochondrial DNA (mtDNA). Replenishment of mtDNA might improve neuronal bioenergetic fu...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.023

    authors: Keeney PM,Quigley CK,Dunham LD,Papageorge CM,Iyer S,Thomas RR,Schwarz KM,Trimmer PA,Khan SM,Portell FR,Bergquist KE,Bennett JP Jr

    更新日期:2009-08-01 00:00:00

  • Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis.

    abstract::Autoimmune destruction of islets in the pancreas leads to the development of insulin-dependent diabetes mellitus (IDDM). Replacement of insulin-producing tissue by transplantation of islets provides a cure to disease but requires immunosuppression or a means of controlling anti-graft immune responses. To promote islet...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.18-2717

    authors: Gallichan WS,Kafri T,Krahl T,Verma IM,Sarvetnick N

    更新日期:1998-12-10 00:00:00

  • Innate immunity to adenovirus.

    abstract::Human adenoviruses are the most widely used vectors in gene medicine, with applications ranging from oncolytic therapies to vaccinations, but adenovirus vectors are not without side effects. In addition, natural adenoviruses pose severe risks for immunocompromised people, yet infections are usually mild and self-limit...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2014.001

    authors: Hendrickx R,Stichling N,Koelen J,Kuryk L,Lipiec A,Greber UF

    更新日期:2014-04-01 00:00:00

  • Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells.

    abstract::Clinical trials of gene therapy using a viral delivery system for glioma have been limited. Recently, gene therapy using stem cells as the vehicles for delivery of therapeutic agents has emerged as a new treatment strategy for malignant brain tumors. In this study, we used human umbilical cord blood-derived mesenchyma...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2010.187

    authors: Ryu CH,Park SH,Park SA,Kim SM,Lim JY,Jeong CH,Yoon WS,Oh WI,Sung YC,Jeun SS

    更新日期:2011-06-01 00:00:00

  • Preclinical safety and biodistribution of adenovirus-based cancer vaccines after intradermal delivery.

    abstract::The recombinant adenoviral (Ad) vector is being considered as a cancer vaccine platform because it efficiently induces immune responses to tumor antigens by intradermal immunization. The aims of this study were to evaluate the potential toxicities and biodistribution after a single dose or six weekly intradermal doses...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.17.705

    authors: Plog MS,Guyre CA,Roberts BL,Goldberg M,St George JA,Perricone MA

    更新日期:2006-07-01 00:00:00

  • Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer.

    abstract::Artemis is a hairpin-opening endonuclease involved in nonhomologous end-joining and V(D)J recombination. Deficiency of Artemis results in radiation-sensitive severe combined immunodeficiency (SCID) characterized by complete absence of T and B cells due to an arrest at the receptor recombination stage. We have generate...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.162

    authors: Multhaup M,Karlen AD,Swanson DL,Wilber A,Somia NV,Cowan MJ,McIvor RS

    更新日期:2010-07-01 00:00:00

  • A method of limited replication for the efficient in vivo delivery of adenovirus to cancer cells.

    abstract::Replication-deficient viral vectors are currently being used in gene transfer strategies to treat cancer cells. Unfortunately, viruses are limited in their ability to diffuse through tissue. This makes it virtually impossible to infect the majority of tumor cells in vivo and results in inadequate gene transfer. This p...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.8-1209

    authors: Han JS,Qian D,Wicha MS,Clarke MF

    更新日期:1998-05-20 00:00:00

  • Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using a bicistronic MDR retrovirus and a new selection strategy.

    abstract::Retrovirus-mediated gene transfer is currently the most common method for the application of genetic therapy to cancer and many inherited and acquired disorders. Here we report the generation of an amphotropic producer cell line (CA2) that synthesizes viral particles carrying a bicistronic cassette in which the select...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1996.7.17-2165

    authors: Aran JM,Licht T,Gottesman MM,Pastan I

    更新日期:1996-11-10 00:00:00

  • Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon.

    abstract::Direct arterial gene transfer has been previously achieved using double-balloon catheters and perforated balloons, in most cases facilitated by the use of cationic liposomes or viral vectors. These gene delivery systems, however, have been compromised by issues relating to efficacy and/or safety, and furthermore requi...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1993.4.6-749

    authors: Riessen R,Rahimizadeh H,Blessing E,Takeshita S,Barry JJ,Isner JM

    更新日期:1993-12-01 00:00:00